Funded Tech Companies

Archon Biosciences

Headquartered in Seattle, Archon Biosciences raised its funding from DUMAC, Alexandria Venture Investments and Pack Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Archon Biosciences is a biotechnology company developing geometrically tunable protein therapeutics with differentiated distribution, engagement and function to target pathways other technologies cannot. This new biologic class, the Antibody Cage (AbC), was invented with the science and technology recognized by the 2024 Nobel Prize in Chemistry at the Baker Lab in the Institute for Protein Design (IPD).

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/30/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Technical Officer

George Ueda

        

Co-Founder

David Baker

        

Co-Founder

James Lazarovits

        

Co-Founder

Lance Stewart

        

VP - Bus. Development

Craig Halder

        

VP - R & D

Jon Graves

        

Company Investors

• DUMAC
• Alexandria Venture Investments
• Pack Ventures
• Cornucopian Capital
• Madrona Venture Group
• Sahsen Ventures
• WRF Capital

Browse more funded tech companies:

ArchiveSocial | ArchPro Design Automation

Share this article

About Our VC Transaction Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary